ArticleBriefings in bioinformatics2025
PanThera: predictive analysis of higher-order combination therapies using deep neural networks.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper develops a deep neural network that accepts cell descriptors and molecules of multiple administered drugs and predicts the joint dose-response hypersurface of the combinatorial treatment. Since the dose-response hypersurface over several concentration dimensions fully characterizes the interaction dynamics of the administered drugs, the model is a computational tool that guides the discovery of synergistic treatments. The neural network is a biochemistry-informed universal approximator; it can estimate any shape of a dose-response hypersurface and has desirable invariances built into its architecture. The model excels at interpolating and extrapolating dose-response surfaces; its predictions align well with known mechanisms of action (MOA). It is the first model that can estimate joint dose-response hypersurfaces of arbitrarily many drugs, including untried combinations, in the presence of arbitrary, potentially nonlinear interactions between drugs. We release the model itself as well as a database of likely synergistic drug triplets. Our code is available at https://github.com/alonsocampana/PanThera/; the database of likely synergistic drug triplets at https://zenodo.org/records/14001717.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.